companydata.dkcompanydata.dk

Nordic Liposomes ApS: Financial statements 2023

CVR: 43161725

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Nordic Liposomes ApS (CVR 43161725) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 104,123 and a net result of DKK 67,655. Equity in the 2023 report amounted to DKK 39,874. The solvency ratio was 9.7%.

Gross Profit
DKK 104,123
Profit/Loss
DKK 67,655
Equity
DKK 39,874
Total Assets
DKK 412,136
Employees
0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Nordic Liposomes ApS publishes interim reportJun 8, 2023

Nordic Liposomes ApS has published its interim report for the period March 28, 2022 to December 31, 2022.

About Nordic Liposomes ApS

Nordic Liposomes ApS is a Danish company of the type Anpartsselskab based in Søndersø, founded in 2022. The company is registered under the industry Andre fremstillingsaktiviteter i.a.n.. The company was previously named Nordicliposomes ApS. The management consists of Morten Thvilum and Trine Albers Huusfeldt. The company is owned by CIRRUS HOLDING ApS and Huusfeldt ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 546,069 and a net result of DKK 336,862 compared with DKK 66,871 the year before. Equity in the 2025 report amounted to DKK 443,608.

Source: annual report 2025, Danish Business Authority

Other financial years